Clinical Application of Simcyp-Guided Warfarin Initiation Doses in Cirrhotic Patients With Portal Vein Thrombosis
NCT07571460
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Liver Cirrhosis
Portal Vein Thrombosis
Interventions
DRUG:
Warfarin 3 mg
DRUG:
Warfarin 2 mg
Sponsor
Kafrelsheikh University